Lite Strategy

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

A propos de Lite Strategy

Fondé

2018

Communauté

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Détails du financement

Cycle de fundingMontantEstimation
Date
Investisseurs
Post-IPO
€85.39M
--
2025-07-21
--